Compare ONEG & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONEG | PDSB |
|---|---|---|
| Founded | 2021 | 2005 |
| Country | Hong Kong | United States |
| Employees | 26 | 10 |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.3M | 29.6M |
| IPO Year | N/A | 2015 |
| Metric | ONEG | PDSB |
|---|---|---|
| Price | $3.59 | $1.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 574.0K | ★ 841.4K |
| Earning Date | 01-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.16 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.96 | $0.51 |
| 52 Week High | $13.50 | $1.90 |
| Indicator | ONEG | PDSB |
|---|---|---|
| Relative Strength Index (RSI) | 74.14 | 74.98 |
| Support Level | $1.16 | $1.02 |
| Resistance Level | $5.70 | $1.12 |
| Average True Range (ATR) | 0.43 | 0.11 |
| MACD | 0.21 | 0.06 |
| Stochastic Oscillator | 92.31 | 90.37 |
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.